Skip to main content
background gradient

Volume 4Issue 5

Editorial

Free Access
To (genetic) test or not to test, that is the question
  • Alvin I Mushlin
pp429–431
Published Online:21 September 2015

Research Article

Free Access
Long-term cost–effectiveness of Oncotype DX® versus current clinical practice from a Dutch cost perspective
  • Michelle Kip,
  • Helma Monteban, and
  • Lotte Steuten
pp433–445
Published Online:15 April 2015
Preview Abstract
Open Access
Treatment costs for advanced prostate cancer using luteinizing hormone-releasing hormone agonists: a solid biodegradable leuprorelin implant versus other formulations
  • Axel S Merseburger,
  • Thomas Björk,
  • James Whitehouse, and
  • Davide Meani
pp447–453
Published Online:18 December 2014
Preview Abstract
Free Access
Can statistical linkage of missing variables reduce bias in treatment effect estimates in comparative effectiveness research studies?
  • William Crown,
  • Jessica Chang,
  • Melvin Olson,
  • Kristijan Kahler,
  • Jason Swindle,
  • Paul Buzinec,
  • Nilay Shah, and
  • Bijan Borah
pp455–463
Published Online:5 October 2015
Preview Abstract
Free Access
Stakeholder assessment of comparative effectiveness research needs for Medicaid populations
  • Michael A Fischer,
  • Cora Allen-Coleman,
  • Stephen F Farrell, and
  • Sebastian Schneeweiss
pp465–471
Published Online:21 September 2015
Preview Abstract
Open Access
Evaluation of techniques for handling missing cost-to-charge ratios in the USA Nationwide Inpatient Sample: a simulation study
  • Tzy-Chyi Yu and
  • Huanxue Zhou
pp473–483
Published Online:21 September 2015
Preview Abstract
Free Access
Systematic overview of cost–effectiveness thresholds in ten countries across four continents
  • Ruth Schwarzer,
  • Ursula Rochau,
  • Kim Saverno,
  • Beate Jahn,
  • Bernhard Bornschein,
  • Nikolai Muehlberger,
  • Magdalena Flatscher-Thoeni,
  • Petra Schnell-Inderst,
  • Gaby Sroczynski,
  • Martina Lackner,
  • Imke Schall,
  • Ansgar Hebborn,
  • Karl Pugner,
  • Andras Fehervary,
  • Diana Brixner, and
  • Uwe Siebert
pp485–504
Published Online:22 October 2015
Preview Abstract

Review

Free Access
Revascularization options in stable coronary artery disease: it is not how to revascularize, it is whether and when to revascularize
  • Mikhail T Torosoff,
  • Mandeep S Sidhu,
  • Karan P Desai,
  • Steven A Fein, and
  • William E Boden
pp505–514
Published Online:21 September 2015
Preview Abstract
Free Access
Using community-based participatory research in patient-centered outcomes research to address health disparities in under-represented communities
  • Yewande Sofolahan-Oladeinde,
  • C Daniel Mullins, and
  • Claudia R Baquet
pp515–523
Published Online:5 October 2015
Preview Abstract
Free Access
Improving the evidence base for better comparative effectiveness research
  • James M Brophy
pp525–535
Published Online:21 September 2015
Preview Abstract